Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

By sjmartinez • May 8, 2024

Lurain K, Zarif TE, Ramaswami R, Nassar AH, Adib E, Abdel-Wahab N, Chintapally N, Drolen CE, Feldman T, Haykal T, Nebhan CA, Kambhampati S, Li M, Mittra A, Lorentsen M, Kim C, Drakaki A, Morse M, Johnson DB, Mangla A, Dittus C, Ravi P, Baiocchi RA, Chiao EY, Rubinstein PG, Yellapragada SV, LaCasce AS, Sonpavde GP, Naqash AR, Herrera AF. Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States. Clin Lymphoma Myeloma Leuk. 2024 Apr 5:S2152-2650(24)00134-4. doi: 10.1016/j.clml.2024.03.011. Epub ahead of print. PMID: 38714474.

Tags: Anti-PD-1, checkpoint inhibitors, General Internal Medicine, Hematology/Oncology, HIV/AIDS, Publications, Resident

Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test

Zeng W, Liu CC, Li S, Zhou Y, Stackpole ML, Xiao Y, Hu R, Tang C, Liu Q, Zeng W, Yeh A, Melehy A, Tran[...]

Clinician Perceptions of the Impact of Switching HPV Vaccine Initiation to 9-10 Years

Szilagyi PG, Gurfinkel D, Clark E, Albertin C, Saville A, O'Leary ST, Beaty B, Vangala S, Woo H, Golden C, Singh J, Kempe A. Clinician[...]

Meaningful within-person change estimates do not identify responders to treatment

Channick JE, Hays RD. Meaningful within-person change estimates do not identify responders to treatment. Alzheimers Dement. 2026 Apr;22(4):e71339. doi: 10.1002/alz.71339. PMID: 41930608.